RIA
WX

Rushmore Investment Advisors’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Rushmore Investment Advisors’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$590K Buy
+28,109
New +$549K 0.12% 136

Other funds holding WX

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $31.2B AUM 40.61% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Rushmore Investment Advisors's WX Position: Q2 2013 in Review

Rushmore Investment Advisors opened a new position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2013: 28,109 shares worth $590K. The stake represents 0.12% of the portfolio and ranks #136 among its holdings.

113 funds tracked by Wall St. Rank hold WX as of Q2 2013.

  • Rushmore Investment Advisors held 28,109 shares of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS worth $590K as of Q2 2013.
  • WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS was a new Rushmore Investment Advisors position in Q2 2013.
  • WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS made up 0.12% of Rushmore Investment Advisors's portfolio in Q2 2013, its #136 holding.
  • 113 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2013.

Based on Rushmore Investment Advisors's 13F filing for Q2 2013, filed 29 Aug 2013.